Fulcrum Therapeutics (FULC) Non-Current Assets: 2019-2025
Historic Non-Current Assets for Fulcrum Therapeutics (FULC) over the last 7 years, with Sep 2025 value amounting to $9.0 million.
- Fulcrum Therapeutics' Non-Current Assets fell 21.91% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 21.91%. This contributed to the annual value of $10.8 million for FY2024, which is 30.33% down from last year.
- Per Fulcrum Therapeutics' latest filing, its Non-Current Assets stood at $9.0 million for Q3 2025, which was down 4.97% from $9.5 million recorded in Q2 2025.
- Over the past 5 years, Fulcrum Therapeutics' Non-Current Assets peaked at $21.0 million during Q2 2022, and registered a low of $9.0 million during Q3 2025.
- Its 3-year average for Non-Current Assets is $13.4 million, with a median of $14.0 million in 2024.
- As far as peak fluctuations go, Fulcrum Therapeutics' Non-Current Assets surged by 124.02% in 2022, and later crashed by 32.25% in 2025.
- Fulcrum Therapeutics' Non-Current Assets (Quarterly) stood at $9.0 million in 2021, then skyrocketed by 112.91% to $19.2 million in 2022, then fell by 19.15% to $15.5 million in 2023, then slumped by 30.33% to $10.8 million in 2024, then fell by 21.91% to $9.0 million in 2025.
- Its Non-Current Assets was $9.0 million in Q3 2025, compared to $9.5 million in Q2 2025 and $10.1 million in Q1 2025.